pharmaceutical companies

Why Samsung Electronics Should Say No to Drugs

Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis.

It's Getting Harder to Come Up With a Successful Drug

The odds of shepherding a new drug to market in recent years has fallen to nearly one in 10 -- about half of the previous rate, according to a new study released this week. First, a new treatment must survive several layers of clinical studies -- and then the FDA approval process.

Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year

Vivus shares are soaring this morning, even though the U.S. Food and Drug Administration rejected the drugmaker's obesity drug Qnexa yesterday. Investors are hoping that the FDA's rejection, which includes a request for more safety data -- not another clinical trial -- will lead to approval next year.

Earnings, Deals, Hiring: A Busy Day for Big Pharma

Big Pharma didn't rest Thursday, with Celgene, Sanofi-Aventis and AstraZeneca among the big names reporting earnings. A deal between Stryker and Boston Scientific and Sanofi and BMP Sunstone also made the headlines, as did some hiring from Teva. Bristol-Myers Squibb received the anticipated new approval for one of its cancer drugs. But it was Celgene that led drug stocks higher.

World Drug Sales to Hit $880 Billion in 2011

Global pharmaceutical sales are expected to grow by 5% to 7% in 2011 to around $880 billion, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in the developed world.

The 25 Companies That Cut 700,000 Jobs

Since the recession began, more than 8 million Americans have lost their jobs. But perhaps even more surprising is the small number of companies that are responsible for laying off such a large percentage of today's unemployed workers.